Blue Plus Provider Manual 2
တၢ်ဃုသ့ၣ်ညါတၢ်အစၢ
တၢ်ပာ်ဖျါ 2641 - 2650 လၢ 4296 အစၢတဖၣ်အကျါ
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP1-25 Commercial Pharmacy Benefit Exclusion for Aucatzyl® and Rapiblyk™
တၢ်ရဲၣ်တၢ်ကျၢၤစးထီၣ်မူ၀ဲ အမုၢ်နံၤမုၢ်သီ- လါယနူၤအါရံၤ 08, 2025
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP3-25 Post-Payment Medical Necessity Review of Inpatient Admissions
တၢ်ရဲၣ်တၢ်ကျၢၤစးထီၣ်မူ၀ဲ အမုၢ်နံၤမုၢ်သီ- လါယနူၤအါရံၤ 08, 2025
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP2-25 MHCP Pharmacy Benefit Exclusion for Aucatzyl®, Axtle™, Boruzu®, Rapiblyk™ and Ziihera®
တၢ်ရဲၣ်တၢ်ကျၢၤစးထီၣ်မူ၀ဲ အမုၢ်နံၤမုၢ်သီ- လါယနူၤအါရံၤ 08, 2025
တၢ်န့ၢ်ဘျုးဒီးတၢ်ဟ့ၣ်အဘူးအလဲ
တၢ်ဃုပှ့ၤတၢ် ဒီးတၢ်မၤလိ
How to Read Your Explanation of Health Care Benefits (EOB) Statement
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
P19R2-18 Update: New Remittance Code OA-45/N801 for Purchased/Referred Care (PRC) - Eligible Subscribers
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲ အမုၢ်နံၤမုၢ်သီ- လါမ့ၤ 01, 2018
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
P26-17 New Drug-Related Prior Authorization (PA) Criteria: Urea Cycle Disorders
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲ အမုၢ်နံၤမုၢ်သီ- လါမ့ၤ 25, 2017
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
P54-16 Added Reimbursement Policies
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါနိၣ်၀့ဘၢၣ် 14, 2016
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
P18-17 New Drug-Related Prior Authorization Requirements for Nusinersen (Spinraza)
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲ အမုၢ်နံၤမုၢ်သီ- လါမ့ၤ 02, 2017
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
P59-18 New Acupuncture Update for Commercial Lines of Business - Effective January 1, 2019
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါနိၣ်၀့ဘၢၣ် 01, 2018